SciELO - Scientific Electronic Library Online

 
vol.38 issue1Vll Edition of Quincke´s Scholarship: Lecture HighlightsClinical and electrophysiological correlation in patient with optic neuritis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

My SciELO

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Investigaciones Biomédicas

Print version ISSN 0864-0300On-line version ISSN 1561-3011

Rev Cubana Invest Bioméd vol.38 no.1 Ciudad de la Habana Jan.-Mar. 2019  Epub Aug 30, 2019

 

Short communication

Melatonin and its neuroimmunological actions

Jorge Ramón Blanco-Carmona1 

William Quintero-Pérez1 

Alexander Ariel Padrón-González2  * 

Maricarmen González-Costa2 

Meralys Iglesias del Valle1 

1Pepe Portilla Provincial Pediatric Hospital. Pinar del Río. Cuba

2Institute of Basic and Preclinical Sciences "Victoria de Girón". University of Medical Sciences of Havana. Cuba

ABSTRACT

Introduction:

Melatonin is a neurohormone, synthesized mainly in the pineal gland, which regulates the circadian rhythm.

Objective:

To describe the neuroimmunological actions produced by melatonin.

Methods:

A review on the subject was carried out using articles of free access in the Pubmed database from 2015 to January 2019.

Discussion:

The effects of melatonin on the wake-sleep cycle are known. Recently it has been shown that this neurohormone can modulate the immune response and reduce seizures in autoimmune and rheumatologic diseases. It induces the pattern of regulatory T lymphocytes and immunomodulatory cytokines maintaining the homeostasis of the internal environment. In the Central Nervous System inhibits the formation of free radicals, has antioxidant functions and can slow neurodegenerative processes. In the peripheral nerves decreases oxidative stress and cellular apoptosis. There are drugs that use melatonin as an active ingredient for its beneficial effects. In Cuba, only the history of a publication on this hormone is collected.

Conclusions:

Melatonin can be a very useful element in the management of inflammatory and neurological diseases.

Keywords: melatonin; inflammation; neurological diseases; immunological diseases

INTRODUCTION

Melatonin is a neurohormone, synthesized mainly in the pineal gland, which regulates the circadian rhythm. This protein can be synthesized in the skin, retina and bone marrow, and its receptors are distributed in different tissues. 1,2

Foods rich in tryptophan favor its synthesis. Among its actions it can be mentioned that it diminishes the systemic manifestations of inflammation, participates in neurodevelopment, is antioxidant and immunomodulatory. 1,3

The objective of this work is to describe the neuroimmune actions produced by melatonin.

METHODS

A review on the subject was carried out using articles of free access in the Pubmed database from 2015 to January 2019.

DEVELOPMENT

Melatonin is known to modulate the immune response under physiological conditions. T lymphocytes, macrophages, and other cells of innate immunity possess receptors of this neurohormone. Its regulatory actions seem to be related to the levels and activity activation of protein kinases and phosphatases.1,4

In theory it could be used to prevent or treat neurodegenerative diseases because it inhibits the formation of tangles of tau protein and beta amyloid, it is capable of favoring interneuronal communication. However, its mechanism of specific action is currently unknown. Numerous teams of scientists are working to elucidate their functions in inflammation, infections, vaccines, immunosenescence, allergy but some of these results have only been achieved in animal models.2,3

Another interesting aspect of which little is known in how it modulates the immune response in the nervous system under physiological conditions as well as in pathological processes. Many questions remain about this topic.

People are currently under stress, which has increased the incidence of psychosomatic manifestations such as severe headache, sleep disturbances, systemic inflammatory diseases, depression, cancer, cardiovascular diseases among others. Perhaps one of the main causes of these events is the imbalance of the circadian rhythm and therefore the production of melatonin.5

In the world there are many drugs that have melatonin as an active compound. Its majority use is for sleep disorders, but it is necessary to have other considerations for its use. For that reason, future studies are necessary to understand more about their actions at the molecular level.

The table 1 summarizes some of the effects that have been described to date.

Table 1 Neuroimmunological efects of melatonin 

Nervous System Neuroprotective and antiexcitatory action. It inhibits the formation of free radicals, modulates the antioxidant actions of vitamins in neurons. Delays neurodegenerative processes in Alzheimer's, Parkinson's and cerebral ischemia models. In the peripheral nerves, oxidative stress decreases, cell apoptosis and has anti-inflammatory effects. (6,7)
Inmune System In patterns of autoimmune encephalitis, the Th1, Th17 pattern and production of proinflammatory cytokines decrease. Induces the pattern of regulatory T lymphocytes and immunomodulatory cytokines. (8,9)
Reumatological diseases Decreases the onset and severity of symptoms. It has been seen that in rheumatoid arthritis it increases the inflammatory mediators and can aggravate the clinical manifestations. (3, 10)

CONCLUSIONS

Melatonin can be a very useful element in the management of inflammatory and neurological diseases.

REFERENCES

1. Sun H, Huang F-F, Qu S. Melatonin: a potential intervention for hepatic steatosis. Lipids in Health and Disease[Internet]. 2015[consultado 22 Feb 2019];14:75. Disponible en: https://doi.org/10.1186/s12944-015-0081-7 . [ Links ]

2. Ferreira CS, Carvalho KC, Maganhin CC, Paiotti APR, Oshima CTF, Simões MJ et al. Does melatonin influence the apoptosis in rat uterus of animals exposed to continuous light? Apoptosis [Internet]. 2016 [consultado 15 Feb 2019];21(2):155-162. Disponible en: https://link.springer.com/article/10.1007%2Fs10495-015-1195-0Links ]

3. González-Costa M, Padrón González AA. La inflamacióndesdeuna perspectiva inmunológica: desafío a la Medicina en el siglo XXl. Revhabanciencméd [Internet]. 2018 [consultado 20 Mar 2019];18(1):30-44. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2445Links ]

4. Jiunn-Diann L, Shun-Fa Y, Yuan-Hung W, Wen-Fang F, Ying-Chin L, Bing-Chun L, et al. Associations of melatonin receptor gene polymorphisms with Graves' disease.PLoS One [Internet]. 2017[consultado 15 Mar 2019];12(9): e0185529. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185529Links ]

5. Padrón-González AA, Martínez-Infante A. Estrés, Psiconeuroendocrinoinmunología y enfermedades reumatológicas. Actualización del tema. Rev Cuba Reumatol [Internet]. 2018 Dec [cited 2018 Dec 07]; 20(3): e628. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962018000300012&lng=en . [ Links ]

6. EzzatRateb E, Nasr Amin S, El-Tablawy N, Ahmed Rashed L, El-Attar S. Effect of melatonin supplemented at the light or dark period on recovery of sciatic nerve injury in rats. EXCLI J. 2017 Mar 6;16:138-150. doi: 10.17179/excli2016-763. eCollection 2017. [ Links ]

7. Wurtman R. Multiple Sclerosis, Melatonin, and Neurobehavioral Diseases. Front Endocrinol (Lausanne). 2017; 8: 280. Published online 2017 Oct 23. doi: 10.3389/fendo.2017.00280 [ Links ]

8. Gu-Jiun L,Shing-Hwa H,Shyi-Jou C, Chih-Hung W, Deh-Ming Chang C,Huey-Kang S. Modulation by Melatonin of the Pathogenesis of Inflammatory Autoimmune Diseases. Int J Mol Sci. 2013 Jun; 14(6): 11742-11766.Published online 2013 May 31. doi: 10.3390/ijms140611742 [ Links ]

9. Carrillo-Vico A, Lardone PJ, Álvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero JM. Melatonin: Buffering the Immune System.Int J MolSci [Internet]. 2013 [consultado 14 Mar 2019];14(4): 8638-8683Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645767/Links ]

*Author in charge of correspondence: (paxander@infomed.sld.cu)

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License